Learn
Medical EducationEvidence-Based MedicinePatient Education
ICU Toolkit
CalculatorsProtocols & CardsICU Setup
CPT & BillingZad TalkForumContact
Home / Calculators / Pulmonary Embolism Risk Class Calculator (ESC an…

Pulmonary Embolism Risk Class Calculator (ESC and AHA/ACC)

Classifies acute pulmonary embolism by the 2019 ESC risk classes and the 2026 AHA/ACC clinical categories, from hemodynamics, a PESI or sPESI result, RV imaging, cardiac biomarkers and respiratory status.

AHA/ACC 2026 Category
Fill in the fields above to see the result.

How to read the result

AHA/ACC clinical categories (2026)

CategoryDefinitionGuideline direction
ASubclinical: incidental and asymptomaticCan be discharged from the emergency department without admission
B1, B2Symptomatic with a low clinical severity score (PESI class I-II or sPESI 0); B1 subsegmental clot only, B2 segmental or more proximalEarly discharge is generally recommended
C1, C2, C3Symptomatic with an elevated severity score (PESI class III-V or sPESI 1 or more); C1 normal RV and biomarkers, C2 abnormal RV or 1 or more abnormal biomarker, C3 bothHospital admission
D1, D2Incipient cardiopulmonary failure: D1 transient hypotension, D2 normotensive shockHospital admission
E1, E2Cardiopulmonary failure: E1 persistent or recurrent hypotension with cardiogenic shock (compatible with SCAI SHOCK stage C), E2 refractory cardiogenic shock (SCAI D-E) or cardiac arrestHospital admission; systemic or catheter-based thrombolysis, mechanical thrombectomy or surgical embolectomy are reasonable in E1
R modifierC: SpO2 below 90%, respiratory rate 30 or more, or a need for oxygen. D: more than 6 L/min by nasal cannula or a nonrebreather mask. E: respiratory failure needing noninvasive or invasive ventilationAdded to the category, for example C3R

ESC risk classes (2019)

ClassCriteria
HighHemodynamic instability: cardiac arrest; obstructive shock (systolic BP below 90 mmHg, or vasopressors needed to reach 90 despite adequate filling, with end-organ hypoperfusion); or persistent hypotension (systolic BP below 90 mmHg or a fall of 40 mmHg or more for over 15 minutes, not from new arrhythmia, hypovolemia or sepsis)
Intermediate-highPESI class III-V or sPESI 1 or more, with both RV dysfunction on echo or CT and a raised cardiac troponin
Intermediate-lowPESI class III-V or sPESI 1 or more, with one or neither; also PESI class I-II or sPESI 0 with RV dysfunction or a raised troponin
LowPESI class I-II or sPESI 0, without RV dysfunction or a raised troponin

Criteria

  • Transient hypotension (D1): systolic BP below 90 mmHg, or a fall of more than 40 mmHg, that lasts under 15 minutes or responds to IV fluids (generally 500-1,000 mL of saline), without signs of reduced perfusion or organ dysfunction. Relative hypotension against the patient’s baseline counts.
  • Normotensive shock (D2): hypoperfusion without persistent hypotension, shown by any of lactate above 2 mmol/L, acute kidney injury, urine below 0.5 mL/kg/h, a change in mental status, cardiac index below 2.2 L/min/m2, MAP below 60 mmHg, or a rising shock stage (SCAI SHOCK B or C) or CPES score.
  • E2 in the guideline text: refractory cardiogenic shock (SCAI D-E) or cardiac arrest without return of spontaneous circulation after 30 minutes of resuscitation; the figure lists cardiac arrest.
  • Clinical severity score: this calculator uses PESI and sPESI. The AHA/ACC guideline also accepts other validated scores and names Bova and Hestia.
  • RV dysfunction on CT: the guideline asks for the numerical RV/LV diameter ratio and reports data for cut-offs of 0.9 and 1.0. On echocardiography (AHA/ACC Table 4 as corrected in July 2026): RV end-diastolic diameter 30 mm or more in the parasternal long axis or basal diameter 41 mm or more, RV/LV end-diastolic ratio above 0.9, or TAPSE 1.7 cm or less.
  • Biomarkers: cardiac troponin I or T and BNP or NT-proBNP above the assay’s reference limit. ESC uses troponin to split intermediate risk; AHA/ACC counts either. When only one biomarker was measured and it is normal, the result names the missing one, since an abnormal value would raise C1 to C2 or C2 to C3. The AHA/ACC guideline adds that lactate should be measured whenever cardiac biomarkers are.
  • ESC 2019 has no category for transient hypotension or normotensive shock, so these patients get an ESC class from PESI or sPESI, RV and troponin, and the result flags it. A systolic BP below 90 mmHg or a fall of 40 mmHg or more lasting over 15 minutes is ESC persistent hypotension, which is high risk; choose that option when it applies.
  • Respiratory status worse than the category’s own modifier (for example a C patient on more than 6 L/min, or a D patient on ventilation): members of the writing committee write that the committee intended such patients to be placed in the higher of the two categories. The guideline figure only adds R, so this calculator keeps the hemodynamic category, adds R and flags the case; check section 3.2 of the guideline.

Evidence

The ESC classes rest on the PESI and sPESI, both validated for 30-day mortality, with RV imaging and troponin added to split intermediate risk. The AHA/ACC categories, introduced in 2026, follow the 2011 AHA massive and submassive terms and the 2019 ESC classes, and add subclinical PE, normotensive shock and a respiratory modifier. The guideline bases normotensive shock on evidence that hypoperfusion without hypotension carries risk: 34% of intermediate-risk patients having mechanical thrombectomy in the FLASH registry had isolated hypoperfusion. It also notes that the first 24 to 72 hours are when hemodynamic collapse is most often seen in trials.

References

  1. Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020;41(4):543-603. PMID 31504429
  2. Creager MA, Barnes GD, Giri J, et al. 2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN guideline for the evaluation and management of acute pulmonary embolism in adults: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2026;153(12):e977-e1051. PMID 41712677
  3. Correction to: 2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN guideline for the evaluation and management of acute pulmonary embolism in adults. Circulation. 2026;154(2):e24. PMID 42441758
  4. Barnes GD, Burnett A, Giri J, et al. The 2026 AHA/ACC guideline for the management of acute pulmonary embolism: what’s new, what changed, and what the newest trials add. Endovascular Today. 2026;25(7 Suppl):9-13. Endovascular Today
  5. Aujesky D, Obrosky DS, Stone RA, et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med. 2005;172(8):1041-1046. PMID 16020800
  6. Jiménez D, Aujesky D, Moores L, et al. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med. 2010;170(15):1383-1389. PMID 20696966
Keep reading

Related articles

All Cardiovascular →

Standardized Team-Based Care for Cardiogenic Shock

BACKGROUND Cardiogenic shock (CS) is a multifactorial, hemodynamically complex syndrome associated with high mortality. Despite advances in reperfusion and mechanical circulatory support, management remains highly variable and out…

October 4, 2022

Basic ECMO Nomenclature

System Support Mode Condition Application ECMO VA ECMO Cardiac failure Cardiac ECMO, ECPR, EISOR VVA ECMO Cardiorespiratory failure Cardiac and respiratory ECMO VV ECMO Respiratory failure Respiratory ECMO VP ECMO RV/respiratory f…

January 23, 2024